uric acid has been researched along with Diathesis in 51 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Previous epidemiological investigations have evaluated the association between gout, serum uric acid levels, and obstructive sleep apnea syndrome (OSAS), but with inconsistent results." | 9.01 | A meta-analysis of the association between gout, serum uric acid level, and obstructive sleep apnea. ( Cheng, C; Liang, M; Min, M; Rizeq, FK; Shi, T; Sun, C; Sun, Y; Zhang, Y, 2019) |
| " In this study we assessed the susceptibility to pentylenetetrazole- and pilocarpine-induced seizures in mice with genetically altered uric acid levels by targeting urate oxidase, which is the enzyme responsible for uric acid breakdown." | 7.83 | Disruption, but not overexpression of urate oxidase alters susceptibility to pentylenetetrazole- and pilocarpine-induced seizures in mice. ( Boon, P; Carrette, E; Delbeke, J; Glorieux, G; Larsen, LE; Portelli, J; Raedt, R; Sprengers, M; Thyrion, L; Van Lysebettens, W; Vonck, K, 2016) |
| "Calcium oxalate stones may form in some patients with gouty diathesis due to increased urinary excretion of calcium and reduced excretion of citrate." | 7.73 | Physicochemical metabolic characteristics for calcium oxalate stone formation in patients with gouty diathesis. ( Moe, OW; Pak, CY; Peterson, RD; Poindexter, JR; Sakhaee, K, 2005) |
| "Abdominal obesity is the main determinant of uric acid variance." | 7.73 | Serum uric acid is a determinant of metabolic syndrome in a population-based study. ( Albayrak, S; Hergenç, G; Karabulut, A; Keleş, I; Onat, A; Sari, I; Uyarel, H; Yazici, M, 2006) |
| "Of the gouty diathesis patients gouty arthritis was present in 21% of those with uric acid and 12% of those with calcium stones." | 7.69 | Clinical and biochemical presentation of gouty diathesis: comparison of uric acid versus pure calcium stone formation. ( Adams-Huet, B; Khatchadourian, J; Pak, CY; Preminger, GM; Whitson, PA, 1995) |
| "The prevalence rates of NAFLD were 71." | 5.43 | Serum uric acid is independently and linearly associated with risk of nonalcoholic fatty liver disease in obese Chinese adults. ( Chen, N; He, CM; Li, X; Li, Z; Liu, CQ; Liu, S; Liu, Y; Shi, X; Wang, D; Yan, B; Yang, S; Zeng, X, 2016) |
| "Previous epidemiological investigations have evaluated the association between gout, serum uric acid levels, and obstructive sleep apnea syndrome (OSAS), but with inconsistent results." | 5.01 | A meta-analysis of the association between gout, serum uric acid level, and obstructive sleep apnea. ( Cheng, C; Liang, M; Min, M; Rizeq, FK; Shi, T; Sun, C; Sun, Y; Zhang, Y, 2019) |
| "It is now well established that intra-articular deposition of endogenous particulates, such as osteoarthritis-associated basic calcium phosphate crystals, gout-associated monosodium urate crystals, and calcium deposition disease-associated calcium pyrophosphate crystals, contributes to joint destruction through the production of cartilage-degrading enzymes and pro-inflammatory cytokines." | 4.98 | Disease-Associated Particulates and Joint Inflammation; Mechanistic Insights and Potential Therapeutic Targets. ( Dunne, A; Mahon, OR, 2018) |
| " The best studied of these diseases is gout, in which crystallization of uric acid in the form of monosodium urate (MSU) mainly in synovial fluid of the joints leads to sterile inflammation." | 3.96 | Binding of Macrophage Receptor MARCO, LDL, and LDLR to Disease-Associated Crystalline Structures. ( Alberts, A; Brand, K; Hoffmeister, L; Klingberg, A; Neumann, K; Pich, A; Wessig, AK, 2020) |
| " In this study we assessed the susceptibility to pentylenetetrazole- and pilocarpine-induced seizures in mice with genetically altered uric acid levels by targeting urate oxidase, which is the enzyme responsible for uric acid breakdown." | 3.83 | Disruption, but not overexpression of urate oxidase alters susceptibility to pentylenetetrazole- and pilocarpine-induced seizures in mice. ( Boon, P; Carrette, E; Delbeke, J; Glorieux, G; Larsen, LE; Portelli, J; Raedt, R; Sprengers, M; Thyrion, L; Van Lysebettens, W; Vonck, K, 2016) |
| " The cut-off point varied in subjects with various cardiovascular risk profiles such as serum uric acid level, gender or hypertension." | 3.76 | Very low-grade albuminuria reflects susceptibility to chronic kidney disease in combination with cardiovascular risk factors. ( Ahn, JM; Chae, DW; Chin, HJ; Heo, NJ; Kim, S; Lee, TW; Na, KY, 2010) |
| "Calcium oxalate stones may form in some patients with gouty diathesis due to increased urinary excretion of calcium and reduced excretion of citrate." | 3.73 | Physicochemical metabolic characteristics for calcium oxalate stone formation in patients with gouty diathesis. ( Moe, OW; Pak, CY; Peterson, RD; Poindexter, JR; Sakhaee, K, 2005) |
| "Abdominal obesity is the main determinant of uric acid variance." | 3.73 | Serum uric acid is a determinant of metabolic syndrome in a population-based study. ( Albayrak, S; Hergenç, G; Karabulut, A; Keleş, I; Onat, A; Sari, I; Uyarel, H; Yazici, M, 2006) |
| "To test the hypothesis that stone-forming patients with type II diabetes (DM-II) have a high prevalence of uric acid (UA) stones and present with some of the biochemical features of gouty diathesis (GD)." | 3.72 | Biochemical profile of stone-forming patients with diabetes mellitus. ( Ekeruo, W; Moe, O; Pak, CY; Peterson, RD; Pietrow, P; Poindexter, JR; Preminger, GM; Sakhaee, K, 2003) |
| "To develop a diagnostic questionnaire to identify individuals with uric acid hyperproduction and risk of urate tubulointerstitial nephritis (UTIN)." | 3.70 | [Detection of urate tubulointerstitial nephritis: contribution of diagnostic questionnaire]. ( Balkarov, IM, 1999) |
| "Of the gouty diathesis patients gouty arthritis was present in 21% of those with uric acid and 12% of those with calcium stones." | 3.69 | Clinical and biochemical presentation of gouty diathesis: comparison of uric acid versus pure calcium stone formation. ( Adams-Huet, B; Khatchadourian, J; Pak, CY; Preminger, GM; Whitson, PA, 1995) |
| "CYP1A2, CYP2D6 and N-acetyltransferase activities were estimated in 100 patients with bladder cancer and 84 control subjects from measurements of theophylline, metoprolol and isoniazid and their metabolites in urine, respectively." | 3.69 | CYP1A2 activity as a risk factor for bladder cancer. ( Jang, IJ; Kim, SW; Lee, KH; Lee, SH; Lee, SW; Oh, SJ; Shin, SG; Yim, DS, 1994) |
| " Urinary excretion rates of calcium, sodium, chloride, potassium, urinary calcium/creatinine index, the fractional excretion of sodium, potassium and uric acid, the creatinine clearance and serum values of creatinine, urea, uric acid, electrolytes, total proteins, parathormone (intact molecule), plasma renin activity, aldosterone, glucose, and insulin (fasting and after an oral glucose load) were performed in every patient and control subject." | 3.69 | Urinary calcium excretion in treated and untreated essential hypertension. ( Navarro-Antolin, J; Orte, L; Ortuño, J; Quereda, C; Sabater, J; Villafruela, JJ, 1996) |
| "Gout is a common form of inflammatory arthritis where urate crystals deposit in joints and surrounding tissues." | 2.72 | The Role of Advanced Imaging in Gout Management. ( Cao, H; Li, S; Liang, J; Lin, J; Wan, L; Xu, G, 2021) |
| "Type 2 diabetes is a risk factor for nephrolithiasis in general and has been associated with uric acid stones in particular." | 2.72 | Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis. ( Adams-Huet, B; Cameron, MA; Maalouf, NM; Moe, OW; Sakhaee, K, 2006) |
| "Gout is an inflammatory arthritis characterized by red, tender, hot and tumid joints." | 2.55 | The Immunological Basis in the Pathogenesis of Gout. ( Chen, J; Li, X; Qiao, Y; Wang, J; Wu, M; Yang, J, 2017) |
| " Dose-response analysis showed the risk of type 2 diabetes was increased by 6% per 1 mg/dl increment in serum uric acid level (RR 1." | 2.49 | High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies. ( Chen, S; Gao, P; He, FF; Huang, K; Liu, JS; Lv, Q; Meng, XF; Su, H; Tian, XJ; Xiong, J; Zhang, C; Zhu, ZH, 2013) |
| "Uric acid nephrolithiasis (UAN) accounts for 20% of all stones but its prevalence varies between countries." | 2.43 | [Multifactorial disorder: molecular and evolutionary insights of uric acid nephrolithiasis]. ( Esposito, T; Gianfrancesco, F, 2005) |
| "Hyperuricemia was established in rats at week 6 and maintained until week 48 in groups M1, M2 and M3." | 1.62 | Detrimental effects of long-term elevated serum uric acid on cognitive function in rats. ( Gu, CW; Jia, H; Li, SJ; Li, TT; Liu, XR; Nie, ZC; Tang, Y; Tian, T; Xu, WD, 2021) |
| "The prevalence rates of NAFLD were 71." | 1.43 | Serum uric acid is independently and linearly associated with risk of nonalcoholic fatty liver disease in obese Chinese adults. ( Chen, N; He, CM; Li, X; Li, Z; Liu, CQ; Liu, S; Liu, Y; Shi, X; Wang, D; Yan, B; Yang, S; Zeng, X, 2016) |
| "Although increased susceptibility to infection has been observed in subjects with diabetes or obesity, little is known about the relationship between metabolic disorders and increased susceptibility to infection." | 1.36 | Association between capacity of interferon-alpha production and metabolic parameters. ( Fukui, M; Hasegawa, G; Nakamura, N; Nakumura, N; Tominaga, M; Uno, K; Yagi, K; Yoshikawa, T, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (41.18) | 18.7374 |
| 1990's | 5 (9.80) | 18.2507 |
| 2000's | 6 (11.76) | 29.6817 |
| 2010's | 14 (27.45) | 24.3611 |
| 2020's | 5 (9.80) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, Z | 1 |
| Wang, Y | 3 |
| Xun, G | 1 |
| Li, S | 1 |
| Xu, G | 1 |
| Liang, J | 1 |
| Wan, L | 1 |
| Cao, H | 1 |
| Lin, J | 1 |
| Ni, X | 1 |
| Sun, C | 2 |
| Tian, Y | 1 |
| Huang, Y | 2 |
| Gong, T | 1 |
| Song, L | 1 |
| Yang, X | 1 |
| Li, K | 1 |
| Zheng, N | 1 |
| Wang, J | 2 |
| Wu, H | 1 |
| Zhang, R | 1 |
| Wang, G | 1 |
| Qin, J | 1 |
| Alberts, A | 1 |
| Klingberg, A | 1 |
| Hoffmeister, L | 1 |
| Wessig, AK | 1 |
| Brand, K | 1 |
| Pich, A | 1 |
| Neumann, K | 1 |
| Tian, T | 1 |
| Liu, XR | 1 |
| Li, TT | 1 |
| Nie, ZC | 1 |
| Li, SJ | 1 |
| Tang, Y | 1 |
| Gu, CW | 1 |
| Xu, WD | 1 |
| Jia, H | 1 |
| Chen, J | 2 |
| Wu, M | 1 |
| Yang, J | 1 |
| Qiao, Y | 1 |
| Li, X | 3 |
| Mahon, OR | 1 |
| Dunne, A | 1 |
| Fernandes, MJ | 1 |
| Naccache, PH | 1 |
| Shi, T | 1 |
| Min, M | 1 |
| Cheng, C | 1 |
| Zhang, Y | 1 |
| Liang, M | 1 |
| Rizeq, FK | 1 |
| Sun, Y | 1 |
| Lv, Q | 1 |
| Meng, XF | 1 |
| He, FF | 1 |
| Chen, S | 1 |
| Su, H | 1 |
| Xiong, J | 1 |
| Gao, P | 1 |
| Tian, XJ | 1 |
| Liu, JS | 1 |
| Zhu, ZH | 1 |
| Huang, K | 1 |
| Zhang, C | 1 |
| Gradillas-García, A | 1 |
| Álvarez, J | 1 |
| Rubio, JA | 1 |
| de Abajo, FJ | 1 |
| Tzounakas, VL | 1 |
| Georgatzakou, HT | 1 |
| Kriebardis, AG | 1 |
| Papageorgiou, EG | 1 |
| Stamoulis, KE | 1 |
| Foudoulaki-Paparizos, LE | 1 |
| Antonelou, MH | 1 |
| Papassideri, IS | 1 |
| Liu, W | 1 |
| Sigdel, KR | 1 |
| Su, Q | 1 |
| Zhang, YL | 1 |
| Duan, L | 1 |
| Shi, G | 1 |
| Thyrion, L | 1 |
| Portelli, J | 1 |
| Raedt, R | 1 |
| Glorieux, G | 1 |
| Larsen, LE | 1 |
| Sprengers, M | 1 |
| Van Lysebettens, W | 1 |
| Carrette, E | 1 |
| Delbeke, J | 1 |
| Vonck, K | 1 |
| Boon, P | 1 |
| Lee, SW | 2 |
| Lee, SS | 1 |
| Oh, DH | 1 |
| Park, DJ | 1 |
| Kim, HS | 1 |
| Choi, JR | 1 |
| Chae, SC | 1 |
| Yun, KJ | 1 |
| Chung, WT | 1 |
| Choe, JY | 1 |
| Kim, SK | 1 |
| Liu, CQ | 1 |
| He, CM | 1 |
| Chen, N | 1 |
| Wang, D | 1 |
| Shi, X | 1 |
| Liu, Y | 1 |
| Zeng, X | 1 |
| Yan, B | 1 |
| Liu, S | 1 |
| Yang, S | 1 |
| Li, Z | 1 |
| Tominaga, M | 1 |
| Uno, K | 1 |
| Yagi, K | 1 |
| Fukui, M | 1 |
| Hasegawa, G | 1 |
| Yoshikawa, T | 1 |
| Nakamura, N | 1 |
| Nakumura, N | 1 |
| Heo, NJ | 1 |
| Ahn, JM | 1 |
| Lee, TW | 1 |
| Chin, HJ | 1 |
| Na, KY | 1 |
| Chae, DW | 1 |
| Kim, S | 1 |
| D'Marco, L | 1 |
| García, I | 1 |
| Vega, C | 1 |
| Pak, CY | 3 |
| Sakhaee, K | 3 |
| Moe, O | 1 |
| Preminger, GM | 2 |
| Poindexter, JR | 2 |
| Peterson, RD | 2 |
| Pietrow, P | 1 |
| Ekeruo, W | 1 |
| MONTANDON, A | 1 |
| BONELLI, M | 1 |
| ZACHARIA, S | 1 |
| TAUPITZ, A | 1 |
| PASERO, G | 1 |
| RICCIONI, N | 1 |
| BIBUS, B | 1 |
| JOVICIC, B | 1 |
| KLIMPEL, W | 1 |
| Moe, OW | 2 |
| Gianfrancesco, F | 1 |
| Esposito, T | 1 |
| Cameron, MA | 1 |
| Maalouf, NM | 1 |
| Adams-Huet, B | 2 |
| Onat, A | 1 |
| Uyarel, H | 1 |
| Hergenç, G | 1 |
| Karabulut, A | 1 |
| Albayrak, S | 1 |
| Sari, I | 1 |
| Yazici, M | 1 |
| Keleş, I | 1 |
| Short, RA | 1 |
| Carel, RS | 1 |
| Shoenfeld, Y | 1 |
| Eldar, M | 1 |
| Silverberg, DS | 1 |
| Eldar, Z | 1 |
| Pinkhas, J | 1 |
| Mor, G | 1 |
| Hanssen, I | 2 |
| Drach, GW | 1 |
| Chernukha, EA | 1 |
| Khaltaeva, ED | 2 |
| Khaltaev, NG | 2 |
| Zhukovskiĭ, GS | 1 |
| Zakharbekov, RR | 1 |
| Akhmeteli, MA | 1 |
| Khatchadourian, J | 1 |
| Whitson, PA | 1 |
| Jang, IJ | 1 |
| Shin, SG | 1 |
| Lee, KH | 1 |
| Yim, DS | 1 |
| Kim, SW | 1 |
| Oh, SJ | 1 |
| Lee, SH | 1 |
| Wiseman, SA | 1 |
| Mathot, JN | 1 |
| de Fouw, NJ | 1 |
| Tijburg, LB | 1 |
| Quereda, C | 1 |
| Orte, L | 1 |
| Sabater, J | 1 |
| Navarro-Antolin, J | 1 |
| Villafruela, JJ | 1 |
| Ortuño, J | 1 |
| Balkarov, IM | 1 |
| Kozhevnikov, EM | 1 |
| Voĭtov, LI | 1 |
| Efimova, MN | 1 |
| Samokhina, RF | 1 |
| Schaible, RH | 1 |
| Astakhova, LN | 1 |
| Asanova, NK | 1 |
| Pochedly, C | 1 |
| Holländer, E | 1 |
| Schwarczmann, P | 1 |
| Eickhorn, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT02797028] | Phase 4 | 320 participants (Anticipated) | Interventional | 2015-01-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for uric acid and Diathesis
| Article | Year |
|---|---|
The Role of Advanced Imaging in Gout Management.
Topics: Biomarkers; Diagnostic Imaging; Disease Management; Disease Susceptibility; Gout; Humans; Hyperurice | 2021 |
The Immunological Basis in the Pathogenesis of Gout.
Topics: Adaptive Immunity; Animals; Disease Susceptibility; Gout; Humans; Immunity, Cellular; Immunity, Humo | 2017 |
Disease-Associated Particulates and Joint Inflammation; Mechanistic Insights and Potential Therapeutic Targets.
Topics: Animals; Arthritis; Biomarkers; Calcium Pyrophosphate; Crystal Arthropathies; Disease Susceptibility | 2018 |
The Role of Inhibitory Receptors in Monosodium Urate Crystal-Induced Inflammation.
Topics: Animals; Costimulatory and Inhibitory T-Cell Receptors; Disease Susceptibility; Gout; Humans; Immuno | 2018 |
A meta-analysis of the association between gout, serum uric acid level, and obstructive sleep apnea.
Topics: Adult; Aged; Biomarkers; Body Mass Index; Brazil; Correlation of Data; Disease Susceptibility; Femal | 2019 |
High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies.
Topics: Diabetes Mellitus, Type 2; Disease Susceptibility; Humans; Prospective Studies; Publication Bias; Ri | 2013 |
[Multifactorial disorder: molecular and evolutionary insights of uric acid nephrolithiasis].
Topics: Animals; Biological Evolution; Cercopithecidae; Chromosomes, Human, Pair 10; Disease Susceptibility; | 2005 |
1 trial available for uric acid and Diathesis
| Article | Year |
|---|---|
Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis.
Topics: Adult; Biomarkers; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disea | 2006 |
43 other studies available for uric acid and Diathesis
| Article | Year |
|---|---|
Individuals with bipolar disorder have a higher level of uric acid than major depressive disorder: a case-control study.
Topics: Adult; Antidepressive Agents; Biomarkers; Bipolar Disorder; Case-Control Studies; Depressive Disorde | 2021 |
Could urinary ACE2 protein level help identify individuals susceptible to SARS-CoV-2 infection and complication?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme 2; Biomarkers; Blood Gluco | 2020 |
Binding of Macrophage Receptor MARCO, LDL, and LDLR to Disease-Associated Crystalline Structures.
Topics: Animals; Biomarkers; Carrier Proteins; Case-Control Studies; Cytokines; Disease Models, Animal; Dise | 2020 |
Detrimental effects of long-term elevated serum uric acid on cognitive function in rats.
Topics: Animals; Biomarkers; Cognition; Cognitive Dysfunction; Cytokines; Disease Models, Animal; Disease Su | 2021 |
[Relationship between vitamin D deficiency and metabolic syndrome in adult population of the Community of Madrid].
Topics: Adult; Aged; Anthropometry; Blood Glucose; Cross-Sectional Studies; Diet; Disease Susceptibility; Fe | 2015 |
Uric acid variation among regular blood donors is indicative of red blood cell susceptibility to storage lesion markers: A new hypothesis tested.
Topics: Adult; Blood Donors; Blood Preservation; Disease Susceptibility; Erythrocytes; Humans; Male; Oxidati | 2015 |
High Level Serum Procalcitonin Associated Gouty Arthritis Susceptibility: From a Southern Chinese Han Population.
Topics: Adult; Aged; Arthritis, Gouty; Arthritis, Rheumatoid; Asian People; Biomarkers; Blood Sedimentation; | 2015 |
Disruption, but not overexpression of urate oxidase alters susceptibility to pentylenetetrazole- and pilocarpine-induced seizures in mice.
Topics: Animals; Brain; Convulsants; Disease Models, Animal; Disease Susceptibility; Mice; Mice, Inbred C57B | 2016 |
Genetic Association for P2X7R rs3751142 and CARD8 rs2043211 Polymorphisms for Susceptibility of Gout in Korean Men: Multi-Center Study.
Topics: Adult; Age of Onset; Asian People; Body Mass Index; CARD Signaling Adaptor Proteins; Case-Control St | 2016 |
Serum uric acid is independently and linearly associated with risk of nonalcoholic fatty liver disease in obese Chinese adults.
Topics: Aged; Biomarkers; China; Disease Susceptibility; Female; Humans; Insulin Resistance; Life Style; Mal | 2016 |
Association between capacity of interferon-alpha production and metabolic parameters.
Topics: Adult; Aged; Blood Glucose; Body Mass Index; Disease Susceptibility; Female; Humans; Hyperglycemia; | 2010 |
Very low-grade albuminuria reflects susceptibility to chronic kidney disease in combination with cardiovascular risk factors.
Topics: Adult; Albuminuria; Cardiovascular Diseases; Chronic Disease; Cohort Studies; Creatinine; Cross-Sect | 2010 |
[Uric acid, atherosclerosis and vascular calcifications in chronic kidney disease].
Topics: Adolescent; Adult; Aged; Atherosclerosis; Calcinosis; Cardiovascular Diseases; Chronic Disease; Como | 2012 |
Biochemical profile of stone-forming patients with diabetes mellitus.
Topics: Adolescent; Adult; Age Factors; Aged; Blood Glucose; Calcium Oxalate; Comorbidity; Diabetes Mellitus | 2003 |
[Uric acid diathesis and deafness].
Topics: Deafness; Disease Susceptibility; Hearing; Hearing Disorders; Hearing Loss; Humans; Uric Acid | 1953 |
[Citrosalicylate of piperazine in therapy of uric acid diathesis].
Topics: Aged; Disease Susceptibility; Gout; Humans; Piperazine; Piperazines; Uric Acid | 1954 |
[Diagnosis of nephrolithiasis with the aid of uric acid diathesis index].
Topics: Calculi; Disease Susceptibility; Humans; Kidney; Kidney Calculi; Nephrolithiasis; Uric Acid | 1959 |
[On the treatment of urate stone diathesis].
Topics: Diet; Diet Therapy; Disease Susceptibility; Humans; Purines; Uric Acid; Urinary Calculi | 1962 |
[2-PHENYL-5-BROMO-1,3-INDANEDIONE IN THE URICOSURIC TREATMENT OF GOUT AND URIC ACID DIATHESIS].
Topics: Disease Susceptibility; Gout; Humans; Indans; Indenes; Phenindione; Uric Acid; Uricosuric Agents | 1963 |
[NEW DEVELOPMENTS IN THE TREATMENT OF URATE DIATHESIS].
Topics: Coal Tar; Disease Susceptibility; Humans; Therapeutics; Uric Acid; Urinary Calculi | 1965 |
[Clinical contribution to uric acid diathesis].
Topics: Disease Susceptibility; Humans; Uric Acid | 1962 |
[Bronchial asthma on the basis of uric acid diathesis].
Topics: Asthma; Disease Susceptibility; Humans; Uric Acid | 1951 |
Physicochemical metabolic characteristics for calcium oxalate stone formation in patients with gouty diathesis.
Topics: Adult; Aged; Calcium Oxalate; Chemical Phenomena; Chemistry, Physical; Disease Susceptibility; Femal | 2005 |
Serum uric acid is a determinant of metabolic syndrome in a population-based study.
Topics: Abdominal Fat; Adult; Aged; Biomarkers; Coronary Disease; Cross-Sectional Studies; Disease Susceptib | 2006 |
Reviewer's perspective of the role of uric acid.
Topics: Adult; Aged; Biomarkers; Coronary Disease; Cross-Sectional Studies; Disease Susceptibility; Female; | 2006 |
Casual blood pressure: its relationship to several cardiovascular risk factors in middle-aged men.
Topics: Blood Glucose; Body Weight; Cardiomegaly; Cardiovascular Diseases; Cholesterol; Cross-Sectional Stud | 1984 |
Clostridium perfringens type A toxins in relation to nephritis and uric acid diathesis in captive willow ptarmigan (Lagopus l. lagopus).
Topics: Animals; Bird Diseases; Birds; Clostridium perfringens; Disease Susceptibility; Enterotoxins; Female | 1982 |
Evaluation of the urinary stone former.
Topics: Adolescent; Adult; Aged; Calcium; Calcium Phosphates; Child; Cystinuria; Diet; Disease Susceptibilit | 1984 |
[Renal colic (uric acid diathesis) and pregnancy].
Topics: Adult; Colic; Diagnosis, Differential; Disease Susceptibility; Female; Humans; Kidney Diseases; Preg | 1983 |
[Determination of normal (desirable) body weight for 40--59-year-old men according to the results of an epidemiologic study of cardiovascular diseases].
Topics: Adult; Age Factors; Blood Pressure; Body Height; Body Weight; Coronary Disease; Disease Susceptibili | 1982 |
[Hyperuricemia, risk factors of ischemic heart disease and the character of nutrition].
Topics: Adult; Alcohol Drinking; Coronary Disease; Dietary Carbohydrates; Disease Susceptibility; Energy Int | 1982 |
Nephritis and uric acid diathesis in captive willow ptarmigan (Lagopus l. lagopus). Effect of feed protein concentration and grass meal admixture.
Topics: Animals; Bird Diseases; Birds; Diet; Dietary Proteins; Disease Susceptibility; Female; Male; Nephrit | 1982 |
Clinical and biochemical presentation of gouty diathesis: comparison of uric acid versus pure calcium stone formation.
Topics: Adult; Age Distribution; Alkalies; Body Mass Index; Calcium; Chemical Phenomena; Chemistry, Physical | 1995 |
CYP1A2 activity as a risk factor for bladder cancer.
Topics: Acetylation; Adult; Aged; Amines; Carcinoma, Transitional Cell; Case-Control Studies; Cytochrome P-4 | 1994 |
Dietary non-tocopherol antioxidants present in extra virgin olive oil increase the resistance of low density lipoproteins to oxidation in rabbits.
Topics: Animals; Antioxidants; Arteriosclerosis; Ascorbic Acid; Coconut Oil; Dietary Fats, Unsaturated; Dise | 1996 |
Urinary calcium excretion in treated and untreated essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aldosterone; Antihypertensive Agents; Benzothiadiazines; Blood G | 1996 |
[Detection of urate tubulointerstitial nephritis: contribution of diagnostic questionnaire].
Topics: Adolescent; Adult; Aged; Disease Progression; Disease Susceptibility; Female; Humans; Male; Middle A | 1999 |
[Uric acid diathesis in chickens].
Topics: Animals; Chickens; Disease Susceptibility; Gout; Kidney Calculi; Poultry Diseases; Uric Acid | 1978 |
Genetic predisposition to purine uroliths in Dalmatian dogs.
Topics: Animals; Creatinine; Disease Susceptibility; Dog Diseases; Dogs; Uric Acid; Urinary Calculi | 1986 |
[Borderline neuropsychiatric disorders in purine metabolism disorders in children].
Topics: Adolescent; Arthritis; Brain Diseases; Child; Child, Preschool; Disease Susceptibility; Female; Huma | 1985 |
Hyperuricemia in leukemia and lymphoma.
Topics: Acetazolamide; Acute Kidney Injury; Allopurinol; Antineoplastic Agents; Bicarbonates; Crystallizatio | 1974 |
[Inhibition of endogenous synthesis of uric acid with allopurinol in patients with gout and urate diathesis].
Topics: Adult; Aged; Allopurinol; Disease Susceptibility; Gout; Humans; Kidney Calculi; Kidney Diseases; Kid | 1969 |
[Urate calculi and urate kidney treatment from the viewpoint of hepato-intestinal dysfunction in uric acid].
Topics: Disease Susceptibility; Female; Humans; Intestinal Diseases; Kidney Calculi; Liver Diseases; Male; M | 1970 |